Company Overview and News

1
Brian Gaynor: KiwiSavers should surf wave of cash

2018-07-13 nzherald.co.nz
The world is awash with cash, and private equity (PE) funds are a clear example of this phenomenon.
IQE RHCGF IQE MPP RYHTY MTPGF RYM

12
Brian Gaynor: Bring greater diversity to the boardroom

2018-06-29 nzherald.co.nz
The Blues' success in the State of Origin thriller and the referee's decisions that supposedly robbed the Wallabies against Ireland weren't the only topics of conversation in Sydney this week.
WYN FBU FBU ANZLY AIR MPP FCREY MTPGF ANZFF ANZFY FRCEF AIZ

2
Sharemarket overvalued, rally hard to justify - Forsyth Barr

2018-06-10 nzherald.co.nz
The sharemarket looks over valued as investors fail to price in uncertainty from the new Government's policies and rising costs, says brokers Forsyth Barr.
ZNZ MPP ZNRGF MTPGF ZEL AUG

2
MARKET WRAP: NZ shares rise despite global dairy prices slipping

2018-06-06 nbr.co.nz
Fat Prophets head of research Greg Smith says investors are 'lapping up' F&P Healthcare's record result.
MPP MTPGF SML

0
Glass manufacturer's profit falls with soft market

2018-05-25 radionz.co.nz
Metro Performance Glass has delivered a disappointing result with net profit down 16 percent on last year.
MPP MTPGF

2
MARKET WRAP: NZ shares fall with Comvita and A2 Milk

2018-05-21 nbr.co.nz
New Zealand shares fell today, led by a poor day of trading for Comvita and A2 Milk.
SKT SYKWF MPP MTPGF SKKTY KWIPF

34
Shares rise as investors second guess index changes; Fletcher gains

2018-05-08 nzherald.co.nz
New Zealand shares rose, joining a regional rally, as investors predict whether an upcoming MSCI index review will spur major activity next week. Fletcher Building, which could exit the index, gains, while new addition a2 Milk Co fell.
CEN TME TRMEF PYIYY AIR FCREY NZTCF ACKDF ANZFY AUKNY AIZ KMD COENF TME CEN KMD KTHDY AIA FBU WBC SPKKY NZTCY SPK WEBNF WBK FRCEF COENY AIA WBC FBU ANZLY MPP MTPGF ANZFF TDMEY MEZ PFI

11
Shares rise as Fletcher jumps on Wesfarmers report

2018-04-13 nzherald.co.nz
New Zealand's benchmark S&P/NZX 50 Index rose, with much of the gain driven by Fletcher Building shares, which lifted on a report Australia's Wesfarmers has taken a small stake. Mercury NZ led decliners and A2 Milk fell on concerns it could be hurt by rivalry in sales of dairy products with the A2 protein variant.
ZNZ SMP FBU SKC FBU MPP FCREY MTPGF ZNRGF FRCEF ZEL SML

0
MARKET WRAP: NZ shares up slightly, Orion down again

2018-04-10 nbr.co.nz
New Zealand shares stayed just above water today, with wins from Pushpay and IkeGPS overcoming further losses for Orion Health.
MPP MTPGF

3
MARKET CLOSE: NZ shares hit record amidst rebalancing, Comvita and Sky TV gain while Pushpay, A2 drop

2018-03-16 nbr.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.
SKT SYKWF VIL PPSHY MPP MTPGF SKKTY GTK

3
NZ shares hit record amidst rebalancing

2018-03-16 nzherald.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.
SKT SYKWF VIL PPSHY MPP MTPGF SKKTY GTK

17
MARKET CLOSE: NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nbr.co.nz
(BusinessDesk) - New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent weakness and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.
FBU FCREY SPKKY EBOSY NZTCY SPK NZTCF FRCEF PGW EBO PGWFY GRO SKT EBOSF SYKWF FBU MPP MTPGF SKKTY PGWFF EBO

17
NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nzherald.co.nz
New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent selling and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.
FBU FCREY SPKKY EBOSY NZTCY SPK NZTCF FRCEF PGW EBO PGWFY GRO SKT EBOSF SYKWF FBU MPP MTPGF SKKTY PGWFF EBO

5
A2 Milk leads sharemarket higher

2018-03-12 nzherald.co.nz
New Zealand shares gained, led higher by A2 Milk Co on index inclusion speculation, with Pushpay and Kathmandu Holdings up.
KTHDY ZNZ BGR PPSHY MPP ZNRGF MTPGF GTK ZEL KMD KMD

5
MARKET CLOSE: NZ shares gain

2018-03-12 nbr.co.nz
(BusinessDesk) - New Zealand shares gained, led higher by A2 Milk Co on index inclusion speculation, with Pushpay and Kathmandu Holdings up.
KTHDY ZNZ BGR PPSHY MPP ZNRGF MTPGF GTK ZEL KMD KMD

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:MPP / METRO PERFORMANCE GLASS LIMITED on message board site Silicon Investor.

MPP-Medical Technology Systems (Was MDTY) Donu0027t Forget Bill Clinton
MPPP - MP3.com AMPP- Reporting
General Cigar Holdings (MPP)